Class effects of SGLT2 inhibitors on cardiorenal outcomes.

Cardiovascular Diabetology
Aaron Y KlugerPeter A McCullough

Abstract

To summarize the four recent sodium-glucose cotransporter 2 inhibitor (SGLT2i) trials: Dapagliflozin Effect on CardiovascuLAR Events (DECLARE-TIMI 58), CANagliflozin CardioVascular Assessment Study (CANVAS) Program, Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients-Removing Excess Glucose (EMPA-REG OUTCOME), Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE), and explore the potential determinants for their cardiovascular, renal, and safety outcomes. The composite renal outcome event rates per 1000 patient-years for drug and placebo, as well as the corresponding relative risk reductions, were 3.7, 7.0, 47%; 5.5, 9.0, 40%; 6.3, 11.5, 46%; 43.2, 61.2, 30% for DECLARE-TIMI 58, CANVAS, EMPA-REG OUTCOME, and CREDENCE, respectively (event definitions varied across trials). The major adverse cardiovascular (CV) event rates per 1000 patient-years for drug and placebo, as well as the corresponding relative risk reductions, were 22.6, 24.2, 7%; 26.9, 31.5, 14%; 37.4, 43.9, 14%; 38.7, 48.7, 20% for DECLARE-TIMI 58, CANVAS, EMPA-REG OUTCOME, and CREDENCE, respectively. DECLARE-TIMI 58 had the fewest cardiorenal events and CREDENCE the most. These differ...Continue Reading

References

Dec 11, 2002·Circulation·Donald M Lloyd-JonesUNKNOWN Framingham Heart Study
Jul 21, 2006·The New England Journal of Medicine·Theophilus E OwanMargaret M Redfield
Sep 26, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Merlin C ThomasGeorge Jerums
Sep 13, 2007·JAMA : the Journal of the American Medical Association·A Michael LincoffSteven E Nissen
Apr 11, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Peter A McCulloughUNKNOWN Kidney Early Evaluation Program Investigators
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Jan 8, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Bryan N Becker, Joseph A Vassalotti
Apr 24, 2010·Journal of the American College of Cardiology·Sanjay KaulUNKNOWN American College Of Cardiology Foundation
Jan 1, 2011·BMJ : British Medical Journal·Douglas G Altman, J Martin Bland
Jun 4, 2013·Lancet·Vivekanand JhaChih-Wei Yang
Mar 5, 2015·Endocrine Reviews·Matthew P Gilbert, Richard E Pratley
Jun 27, 2015·Journal of the American College of Cardiology·Peter A McCulloughRobert C Stoler
Sep 18, 2015·The New England Journal of Medicine·Bernard ZinmanUNKNOWN EMPA-REG OUTCOME Investigators
Jun 15, 2016·The New England Journal of Medicine·Christoph WannerUNKNOWN EMPA-REG OUTCOME Investigators
Jul 16, 2016·European Heart Journal. Cardiovascular Pharmacotherapy·Faiez ZannadGonzalo Calvo
Sep 23, 2016·European Journal of Heart Failure·David H FitchettSilvio E Inzucchi
May 21, 2017·International Journal of Cardiology·Alessandra Di FrancoEdoardo Mannucci
Jun 13, 2017·The New England Journal of Medicine·Bruce NealUNKNOWN CANVAS Program Collaborative Group
Jun 15, 2017·The New England Journal of Medicine·David G ArmstrongSicco A Bus
Jan 13, 2018·Heart Failure Reviews·Abdullah KaplanFouad A Zouein
May 24, 2018·Cardiovascular Diabetology·Daisuke MatsutaniKazunori Utsunomiya
May 26, 2018·Advances in Chronic Kidney Disease·Ragnar Palsson, Sushrut S Waikar
May 29, 2018·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·W Ryan PowellDonald R Miller
Jun 15, 2018·American Heart Journal·Stephen D WiviottMarc S Sabatine
Jul 28, 2018·Cardiovascular Diabetology·Νarjes Nasiri-AnsariEva Kassi
Aug 5, 2018·Journal of the American College of Cardiology·Thomas A Zelniker, Eugene Braunwald
Nov 13, 2018·The New England Journal of Medicine·Stephen D WiviottUNKNOWN DECLARE–TIMI 58 Investigators
Jan 5, 2019·Diabetes, Obesity & Metabolism·Dario GiuglianoKatherine Esposito
Apr 2, 2019·Expert Opinion on Drug Safety·André J Scheen
Apr 17, 2019·The New England Journal of Medicine·Vlado PerkovicUNKNOWN CREDENCE Trial Investigators
Apr 30, 2019·Reviews in Cardiovascular Medicine·Aaron Y KlugerPeter A McCullough

❮ Previous
Next ❯

Citations

May 8, 2020·Naunyn-Schmiedeberg's Archives of Pharmacology·Marina KrasnovaAlexey Smirnov
Feb 6, 2020·Diabetic Medicine : a Journal of the British Diabetic Association·A RajaniA Amar
Feb 1, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Oshini ShivakumarDavid C Wheeler
Sep 5, 2020·Journal of Diabetes·Theocharis KoufakisKalliopi Kotsa
Sep 24, 2020·Expert Opinion on Pharmacotherapy·Kevin Cowart, Nicholas W Carris
May 22, 2020·Circulation Research·Rebecca H Ritchie, E Dale Abel
Jun 17, 2020·Cardiovascular Diabetology·Rafael Y BrzezinskiShani Shenhar-Tsarfaty
Apr 18, 2020·The Journal of Clinical Endocrinology and Metabolism·Nicola FlemingElif I Ekinci
Sep 29, 2020·Circulation·Janani RangaswamiUNKNOWN American Heart Association Council on the Kidney in Cardiovascular Disease; Council on Arteriosclerosis, Thrombosis and Vasc
Oct 2, 2020·Diabetes, Obesity & Metabolism·Victor OkunrintemiDoyle M Cummings
Dec 9, 2020·Cardiovascular Diabetology·Atsushi Tanaka, Koichi Node
Oct 22, 2020·Diabetes & Metabolism Journal·Päivi Maria Paldánius
Nov 24, 2020·Cardiovascular Diabetology·Francesco GiorginoAnna Solini
Nov 14, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·David M WilliamsMarc Evans
Mar 4, 2021·Pharmacological Reviews·Franck Mauvais-JarvisJoshua B Rubin
Mar 30, 2021·Kidney International Supplements·Peter A McCullough
Mar 31, 2021·Life Sciences·Mohammed Ali AzamKumaraswamy Nanthakumar
Apr 24, 2021·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Fotios BarkasHaralampos Milionis
Apr 30, 2021·Cardiovascular Diabetology·Chu LinLinong Ji
May 5, 2021·Journal of the Royal Society of Medicine·Zay M Htet, Mahzuz Karim
Jun 23, 2021·International Journal of Urology : Official Journal of the Japanese Urological Association·Mohit ChandrashekarMarlon Perera
Jul 3, 2021·Journal of Clinical Medicine·Angelo CignarelliFrancesco Giorgino
Jul 3, 2021·Journal of Clinical Medicine·Vicente Martínez-VizcaínoIván Cavero-Redondo
Jul 13, 2021·Cardiology Clinics·Enrico G FerroDeepak L Bhatt

❮ Previous
Next ❯

Methods Mentioned

BETA
amputation

Software Mentioned

CREDENCE

Related Concepts

Related Feeds

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.